A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK127 in Combination With AK104 in Advanced and Metastatic Solid Tumours

NCT05021120 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced or Metastatic Solid Tumours

Interventions

DRUG: AK127
DRUG: AK104

Sponsor

Akesobio Australia Pty Ltd